Skip to content
  • About Us
  • Investment Focus
  • Team
  • Portfolio
  • News
  • Contact Us
Brainsway Receives CE Approvals for Treating Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD)

Brainsway Receives CE Approvals for Treating Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD)